20
Participants
Start Date
July 27, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Citicoline supplement
Participants with AD will receive a dietary citicoline supplement. Subjective sleep measures will be measured via the Pittsburgh Sleep Quality Index (for measurement of sleep quality) and Epworth Sleepiness Scale (for measurement of sleepiness). Cognition will be measured by Rey Auditory Verbal Learning Test (RAVLT), Trail Making Test (TMT) Parts A \& B, and the Montreal Cognitive Assessment (MOCA). Participants will complete all questionnaires at baseline and at follow-up at 3 months.
Placebo
Participants with AD will receive a placebo supplement. Subjective sleep measures will be measured via the Pittsburgh Sleep Quality Index (for measurement of sleep quality) and Epworth Sleepiness Scale (for measurement of sleepiness). Cognition will be measured by Rey Auditory Verbal Learning Test (RAVLT), Trail Making Test (TMT) Parts A \& B, and the Montreal Cognitive Assessment (MOCA). Participants will complete all questionnaires at baseline and at follow-up at 3 months.
Emory University School of Nursing, Atlanta
Goizueta Alzheimer's Disease Research Center, Atlanta
National Institute on Aging (NIA)
NIH
Emory Goizueta Alzheimer's Disease Research Center (ADRC)
UNKNOWN
Emory University
OTHER